Allergy/Asthma News

IV magnesium therapy administered after initial asthma treatment in the ED was associated with subsequent hospitalization in children with refractory acute asthma, according to findings published in JAMA Network Open.

Coexisting bronchiectasis in patients with asthma and chronic rhinosinusitis is common and associated with more severe disease, according to new findings published in BMC Pulmonary Medicine.

A new study published in BMC Pulmonary Medicine identified independent risk factors for severe adult-onset asthma, including smoking, NSAID-exacerbated respiratory disease, male sex and two or more siblings.

GlaxoSmithKline announced that the FDA has approved Nucala as a treatment for adults who have chronic rhinosinusitis with nasal polyps.

Hormone therapy with exogenous estrogen, with and without progesterone, may increase the risk for asthma in women, according to new research published in Chest.

Most patients with “immediate and potentially allergic reactions” to the Pfizer/BioNTech and Moderna COVID-19 vaccines tolerated a second dose, researchers reported in JAMA Internal Medicine.

A new phase 2 clinical trial of multiple therapies to treat patients with severe asthma, specifically focusing on personalized therapies based on genetics, family history, lifestyle and environmental factors, is currently underway.

In a new study, childhood-onset asthma was associated with a low educational level in young adulthood, researchers reported in Respiratory Medicine.

Patients with asthma-COPD overlap have elevated risk for lung cancer compared with smokers and similar rates of lung cancer compared with those with COPD, but greater risk than patients with asthma alone, researchers reported.

Long-term treatment with dupilumab helped patients with oral corticosteroid-dependent asthma wean their oral corticosteroid use and also reduced exacerbations and improved lung function.